bulimia nervosa

GPTKB entity

Statements (56)
Predicate Object
gptkbp:instanceOf eating disorder
gptkbp:affects adolescents
young adults
predominantly females
gptkbp:alsoKnownAs bulimia
gptkbp:associatedWith gptkb:depression
substance abuse
anxiety disorders
gptkbp:canBeFatal yes
gptkbp:cause gptkb:arrhythmia
gptkb:Russell's_sign
chronic health problems
gastrointestinal problems
menstrual irregularities
parotid gland swelling
gptkbp:characterizedBy binge eating
compensatory behaviors
gptkbp:compensatoryBehaviorsInclude excessive exercise
misuse of laxatives
self-induced vomiting
gptkbp:complication dehydration
electrolyte imbalance
dental erosion
esophageal damage
gptkbp:diagnosedBy gptkb:DSM-5_criteria
gptkbp:diagnosisRequires episodes occur at least once a week for 3 months
inappropriate compensatory behaviors
recurrent episodes of binge eating
self-evaluation unduly influenced by body shape and weight
gptkbp:DSM-5_code 307.51
gptkbp:firstDescribed gptkb:Gerald_Russell
1979
https://www.w3.org/2000/01/rdf-schema#label bulimia nervosa
gptkbp:ICD-10_code F50.2
gptkbp:mortalityRate elevated compared to general population
gptkbp:onset adolescence
young adulthood
gptkbp:prevalence more common in females
gptkbp:prognosis variable
gptkbp:relatedTo anorexia nervosa
binge eating disorder
gptkbp:riskFactor genetic predisposition
psychological stress
cultural pressure
gptkbp:symptom fear of gaining weight
preoccupation with body weight
gptkbp:treatment cognitive behavioral therapy
nutritional counseling
antidepressant medication
gptkbp:bfsParent gptkb:fluvoxamine
gptkb:MAO_inhibitors
gptkb:SSRIs
gptkb:Prozac
gptkb:fluoxetine
gptkb:selective_serotonin_reuptake_inhibitors
gptkbp:bfsLayer 6